T Cell Immunity in Malaria Vaccination Strategies

T cell immunity has emerged as a pivotal component in the development of effective malaria vaccines, complementing humoral responses and addressing the limitations of antibody-focused approaches. Upon inoculation with attenuated or subunit vaccine candidates, antigen-specific CD4+ T helper cells support B cell maturation and antibody production, while CD8+ cytotoxic T lymphocytes patrol the liver, recognising and eliminating infected hepatocytes before parasites progress to the symptomatic blood stage. Memory T cell subsets—particularly tissue-resident and effector memory populations—ensure rapid recall responses upon re-exposure. Advances in whole-organism vaccines, including radiation-attenuated and genetically attenuated sporozoite platforms, have demonstrated that robust T cell activation, characterised by polyfunctional cytokine profiles, correlates strongly with sterilising protection. Key challenges remain in optimising antigen presentation, overcoming host immune suppression during acute blood-stage infection, and achieving durable memory across diverse populations. Integrating insights into T cell priming, trafficking and functional maintenance will guide next-generation regimens capable of preventing both initial infection and transmission in endemic settings.

Research from Nature Portfolio

Recent studies have demonstrated that a single low-dose immunisation with late-arresting genetically attenuated Plasmodium falciparum sporozoites elicits exceptionally high protective efficacy. In a controlled human trial, nine out of ten participants achieved sterile protection six weeks after mosquito-bite administration of the attenuated parasites, compared with none in the control group. This regimen significantly increased circulating sporozoite-specific polyfunctional effector memory CD4+ T cells co-expressing tumour necrosis factor and interleukin-2, underscoring the importance of multifunctional T cell responses for rapid parasite clearance. Another investigation in rodent models revealed that concurrent blood-stage infection suppresses liver-stage development of both wild-type and genetically attenuated parasites through host-derived interferons rather than iron-regulating hormones. This mechanistic insight highlights how inter-stage interference may influence vaccine efficacy and suggests that optimal timing of immunisation relative to endemic exposure is crucial for eliciting effective liver-targeted T cell responses.

T Cell Immunity in Malaria Vaccination Strategies publication trend

The graph below shows the total number of articles in t cell immunity in malaria vaccination strategies across all publications each year (not limited to Nature Index journals).

Technical terms

CD4+ T cells: Helper T lymphocytes that orchestrate immune responses by providing critical signals to B cells and CD8+ T cells.

CD8+ T cells: Cytotoxic T lymphocytes that recognise and kill infected liver cells, preventing parasite maturation.

Effector memory T cells: A subset of memory T cells that circulates through tissues and mounts rapid effector functions upon antigen re-encounter.

Polyfunctional T cells: T lymphocytes capable of producing multiple cytokines simultaneously, associated with heightened protective capacity.

Genetically attenuated parasites: Plasmodium sporozoites engineered to arrest during liver-stage development, serving as whole-organism vaccines without causing disease.

Interferons: Signalling proteins produced by host cells that mediate antiviral and antiparasitic immunity, influencing parasite development.

References

1. Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial. Nature Medicine (2025).
2. Malaria blood stage infection suppresses liver stage infection via host-induced interferons but not hepcidin. Nature Communications (2024).
3. Safety and protective efficacy of PfSPZ vaccine administered to HIV negative and positive Tanzanian adults. Journal of Clinical Investigation (2024).
4. Memory CD8+ T cell‐mediated protection against liver‐stage malaria. Immunological Reviews (2023).
5. Lymph-Node Resident CD8α+ Dendritic Cells Capture Antigens from Migratory Malaria Sporozoites and Induce CD8+ T Cell Responses. PLOS Pathogens (2015).